Table 2.
Baseline Characteristics of Acute Ischemic Stroke Patients According to 90‐Day Functional Outcomes
| 90‐Day poor functional outcomes (mRS ≥ 3) | |||
|---|---|---|---|
| Characteristics | Yes (N = 33) | No (N = 107) | P |
| Demographics | |||
| Male | 20 (60.6) | 75 (70.1) | .31 |
| Age, y | 67 (23) | 59 (17) | .005 |
| Medical histories | |||
| History of hypertension | 24 (72.7) | 68 (63.6) | .33 |
| History of diabetes | 9 (27.3) | 28 (26.2) | .90 |
| History of AF | 11 (33.3) | 6 (5.6) | <.001 |
| History of CHD | 4 (12.1) | 5 (4.7) | .13 |
| History of stroke | 6 (18.2) | 16 (15.0) | .66 |
| Dietary habits | .067 | ||
| Vegetable‐based diet | 8 (24.2) | 25 (23.4) | |
| Mixed diet | 21 (63.6) | 48 (44.9) | |
| Meat‐based diet | 4 (12.1) | 34 (31.8) | |
| Stroke causes | <.001 | ||
| Thrombotic | 19 (57.6) | 44 (41.1) | |
| Lacunar | 0 | 37 (34.6) | |
| Embolic | 10 (30.3) | 11 (10.3) | |
| Other cause | 3 (9.1) | 4 (3.7) | |
| Unknown | 1 (3.0) | 11 (10.3) | |
| Antiplatelet agents | .011 | ||
| Aspirin | 13 (39.4) | 18 (16.8) | |
| Clopidogrel | 9 (27.3) | 26 (24.3) | |
| Aspirin+clopidogrel | 11 (33.3) | 63 (58.9) | |
| Clinical features | |||
| Dysphagia | 26 (78.8) | 15 (14.0) | <.001 |
| Enteral nutrition | 22 (66.7) | 10 (9.3) | <.001 |
| Revascularization | 14 (42.4) | 21 (19.6) | .008 |
| NIHSS score | 13 (10) | 3 (4) | <.001 |
| Defecation time | <.001 | ||
| No more than 48 h after stroke | 8 (24.2) | 70 (65.4) | |
| 48–120 h after stroke | 25 (75.8) | 37 (34.6) | |
| Laboratory findings | |||
| NEU, × 109/L | 6.14 (4.10) | 5.41 (3.42) | .037 |
| NT‐proBNP, pg/mL | 218.50 (1517.82) | 88.47 (257.68) | .007 |
Data were presented as median (interquartile range) or number (%).
AF, atrial fibrillation; CHD, coronary heart disease; mRS, modified Rankin Scale; NEU, neutrophil; NIHSS, National Institutes of Health Stroke Scale; NT‐proBNP, N‐terminal B‐type natriuretic peptide.